Abstract
This paper explores the cost utility of metalon-metal hip resurfacing arthroplasty (MOM) as an alternative intervention to total hip replacement or ‘watchful waiting’ for patients with advanced hip disease. Early implant failure among younger and more active elderly patients can mean that the use of total hip replacement (THR) is delayed, with patients managed through ‘watchful waiting’, a combination of pain control and other non-surgical interventions. Information on costs is combined with evidence on effectiveness from a systematic review in a Markov model in order to estimate the incremental cost per quality adjusted life year (QALY) of MOM relative to THR and ‘watchful waiting’.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Lynda McKenzie Health Economics Research Unit, Department of Public Health, University of Aberdeen, University Medical Buildings, Foresterhill, Aberdeen, AB25 2ZD, UK, e-mail: l.mckenzie@abdn.ac.uk
Rights and permissions
About this article
Cite this article
McKenzie, L., Vale, L., Stearns, S. et al. Metal on metal hip resurfacing arthroplasty . Eur J Health Econom 4, 122–129 (2003). https://doi.org/10.1007/s10198-002-0158-x
Issue Date:
DOI: https://doi.org/10.1007/s10198-002-0158-x